Jazz Pharmaceuticals plc (JAZZ)

G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,104	7,445	7,744	10,031	7,831	9,196
Market Cap Growth	-4.59%	-3.86%	-22.80%	28.09%	-14.84%	8.89%
Enterprise Value	10,868	11,031	11,945	14,946	13,570	9,525
Last Close Price	117.12	123.15	123.00	159.31	127.40	165.05
PE Ratio	-	13.29	18.67	-	-	38.54
Forward PE	5.51	5.72	6.29	8.54	8.23	10.20
PS Ratio	1.75	1.83	2.02	2.74	2.53	3.89
PB Ratio	1.92	1.82	2.07	3.25	1.98	2.51
P/TBV Ratio	-	-	-	-	-	18.16
P/FCF Ratio	5.62	5.48	7.25	8.07	10.43	10.40
P/OCF Ratio	5.40	5.33	7.09	7.89	10.06	10.22
PEG Ratio	0.55	0.37	0.50	1.14	0.62	2.62
EV/Sales Ratio	2.66	2.71	3.12	4.08	4.39	4.03
EV/EBITDA Ratio	6.80	7.25	8.24	10.18	13.20	9.13
EV/EBIT Ratio	11.74	12.80	14.73	17.81	28.55	12.44
EV/FCF Ratio	8.59	8.12	11.18	12.03	18.07	10.77
Debt / Equity Ratio	1.47	1.51	1.55	1.89	1.56	0.62
Debt / EBITDA Ratio	3.33	3.97	3.93	3.90	5.84	2.11
Debt / FCF Ratio	4.30	4.54	5.43	4.68	8.22	2.55
Asset Turnover	0.37	0.35	0.35	0.32	0.33	0.39
Inventory Turnover	0.61	0.58	0.43	0.30	0.37	1.71
Quick Ratio	1.15	3.57	1.52	1.64	1.43	3.87
Current Ratio	1.62	4.46	2.24	2.79	3.23	4.34
Return on Equity (ROE)	-10.84%	14.31%	12.16%	-6.35%	-8.65%	7.05%
Return on Assets (ROA)	5.19%	4.60%	4.56%	4.53%	3.15%	7.92%
Return on Capital (ROIC)	6.19%	5.44%	5.50%	5.51%	3.70%	8.86%
Return on Capital Employed (ROCE)	10.40%	7.90%	8.20%	8.50%	4.10%	13.00%
Earnings Yield	-5.70%	7.52%	5.36%	-2.23%	-4.21%	2.60%
FCF Yield	17.81%	18.24%	13.79%	12.39%	9.59%	9.62%
Buyback Yield / Dilution	12.92%	8.41%	-15.23%	-4.77%	-5.62%	1.80%

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q